Minimal manifestation status and prednisone withdrawal in the MGTX trial

OBJECTIVE: To examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients with myasthenia gravis (MG). METHODS: This study is a post hoc analysis of data from a randomized trial of thymectomy in MG (Thymectomy Trial...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neurology
Main Authors: Lee, Ikjae, Kuo, Hui-Chien, Aban, Inmaculada B., Cutter, Gary R., McPherson, Tarrant, Kaminski, Henry J., Sussman, Jon, Ströbel, Philipp, Oger, Joel, Cea, Gabriel, Heckmann, Jeannine M., Evoli, Amelia, Nix, Wilfred, Ciafaloni, Emma, Antonini, Giovanni, Witoonpanich, Rawiphan, King, John O., Beydoun, Said R., Chalk, Colin H., Barboi, Alexandru C., Amato, Anthony A., Shaibani, Aziz I., Katirji, Bashar, Lecky, Bryan R.F., Buckley, Camilla, Vincent, Angela, Dias-Tosta, Elza, Yoshikawa, Hiroaki, Waddington-Cruz, Marcia, Pulley, Michael T., Rivner, Michael H., Kostera-Pruszczyk, Anna, Pascuzzi, Robert M., Jackson, Carlayne E., Verschuuren, Jan J.G., Massey, Janice M., Kissel, John T., Werneck, Lineu C., Benatar, Michael, Barohn, Richard J., Tandan, Rup, Mozaffar, Tahseen, Conwit, Robin, Minisman, Greg, Sonett, Joshua R., Wolfe, Gil I.
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7455358/
https://ncbi.nlm.nih.gov/pubmed/32611638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000010031
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki